Huw M. Nash, COO & CBO at Stoke Therapeutics, Inc. (STOK), sold 575 shares at $39.43 ($23K) on 2021-06-01, disclosed to the SEC on 2021-06-03.
Scheduled sale ($23k) by COO & CBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| STOK | SELL | 2024-04-03 | $1.6M | — | Filing → |
| STOK | SELL | 2024-03-19 | $25K | — | Filing → |
| STOK | SELL | 2022-01-05 | $88K | — | Filing → |